Factor X Recombinant Rabbit Monoclonal Antibody (3F2), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | FEMA549874-Each-of-1 | In Stock | ₹ 37,202.00 |
FEMA549874 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 37,202.00
GST (18%): ₹ 6,696.36
Total Price: ₹ 43,898.36
Antigen
Factor X
Classification
Recombinant Monoclonal
Concentration
0.9 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide, pH 7.4
Gene Accession No.
P00742
Gene Symbols
F10
Immunogen
A synthesized peptide derived from human Factor X
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Form
Liquid
Applications
ELISA, Immunohistochemistry (Paraffin)
Clone
3F2
Conjugate
Unconjugated
Gene
F10
Gene Alias
Activated factor Xa heavy chain, blood coagulation factor X, Cf10, coagulation factor 10, coagulation factor X, coagulation factor X protein, F10, Factor 10, Factor X heavy chain, Factor X light chain, factor Xa, Factor10, FX, FXA, prothrombinase, RP11-98F14.9, stuart factor, Stuart-Prower factor, Unknown (protein for IMAGE:8121240), unnamed protein product
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
2159
Content And Storage
-20°C or -80°C if preferred
Isotype
IgG
Related Products
Description
- F10 undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR
- Two chains of the factor are held together by 1 or more disulfide bonds; the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases
- The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway)
- The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting
- Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity.